| Dr Alexander Zabaneh, MD | |
|
342 F St, Chula Vista, CA 91910-2625 | |
| (619) 422-1471 | |
| (619) 422-0114 |
| Full Name | Dr Alexander Zabaneh |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 11 Years |
| Location | 342 F St, Chula Vista, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346687233 | NPI | - | NPPES |
| 1346687233 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207WX0009X | Ophthalmology - Glaucoma Specialist | A154697 (California) | Secondary |
| 207W00000X | Ophthalmology | A154697 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Castillejos Eye Institute Medical Group | 8729023478 | 5 |
News Archive
Exposure to the rhinovirus, the most frequent cause of the common cold, can protect against infection by the virus which causes COVID-19, Yale researchers have found.
Case Western Reserve University researchers have discovered that an existing drug used to help cancer patients has the potential to protect thousands of others from the often-deadly impact of vascular clots.
Probi has signed a distribution and supply agreement with Sanofi. Following this the Consumer Healthcare division of Sanofi Korea is making a major launch of Probi´s gut health product, Probi Digestis starting in April 2014. Probi has already delivered products and received substantial orders for the coming quarters.
A clinical trial testing a candidate HIV vaccine known as the STEP study was halted in September 2007 after interim analysis indicated that the vaccine did not work. Moreover, subsequent analyses indicated that the vaccine made some individuals more susceptible to HIV, in particular individuals who had pre-existing immune effectors (antibodies) that recognized a component of the vaccine (adenovirus serotype 5 [Ad5]).
In the most comprehensive review to date of how breast cancer develops, scientists have created a detailed map that describes the many ways in which environmental chemicals can trigger the disease.
› Verified 7 days ago
| Entity Name | Castillejos Eye Institute Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841377660 PECOS PAC ID: 8729023478 Enrollment ID: O20050622001351 |
News Archive
Exposure to the rhinovirus, the most frequent cause of the common cold, can protect against infection by the virus which causes COVID-19, Yale researchers have found.
Case Western Reserve University researchers have discovered that an existing drug used to help cancer patients has the potential to protect thousands of others from the often-deadly impact of vascular clots.
Probi has signed a distribution and supply agreement with Sanofi. Following this the Consumer Healthcare division of Sanofi Korea is making a major launch of Probi´s gut health product, Probi Digestis starting in April 2014. Probi has already delivered products and received substantial orders for the coming quarters.
A clinical trial testing a candidate HIV vaccine known as the STEP study was halted in September 2007 after interim analysis indicated that the vaccine did not work. Moreover, subsequent analyses indicated that the vaccine made some individuals more susceptible to HIV, in particular individuals who had pre-existing immune effectors (antibodies) that recognized a component of the vaccine (adenovirus serotype 5 [Ad5]).
In the most comprehensive review to date of how breast cancer develops, scientists have created a detailed map that describes the many ways in which environmental chemicals can trigger the disease.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alexander Zabaneh, MD 342 F St, Chula Vista, CA 91910-2625 Ph: (619) 422-1471 | Dr Alexander Zabaneh, MD 342 F St, Chula Vista, CA 91910-2625 Ph: (619) 422-1471 |
News Archive
Exposure to the rhinovirus, the most frequent cause of the common cold, can protect against infection by the virus which causes COVID-19, Yale researchers have found.
Case Western Reserve University researchers have discovered that an existing drug used to help cancer patients has the potential to protect thousands of others from the often-deadly impact of vascular clots.
Probi has signed a distribution and supply agreement with Sanofi. Following this the Consumer Healthcare division of Sanofi Korea is making a major launch of Probi´s gut health product, Probi Digestis starting in April 2014. Probi has already delivered products and received substantial orders for the coming quarters.
A clinical trial testing a candidate HIV vaccine known as the STEP study was halted in September 2007 after interim analysis indicated that the vaccine did not work. Moreover, subsequent analyses indicated that the vaccine made some individuals more susceptible to HIV, in particular individuals who had pre-existing immune effectors (antibodies) that recognized a component of the vaccine (adenovirus serotype 5 [Ad5]).
In the most comprehensive review to date of how breast cancer develops, scientists have created a detailed map that describes the many ways in which environmental chemicals can trigger the disease.
› Verified 7 days ago
Dr. Duane M Bryant, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 342 F St, Chula Vista, CA 91910 Phone: 619-422-1471 Fax: 619-422-0114 | |
Emma Coleen Mcdonnell, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 835 Third Ave Ste A, Chula Vista, CA 91911 Phone: 619-425-7755 | |
Majid Mani, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 835 Third Ave, Suite A, Chula Vista, CA 91911 Phone: 619-425-7755 Fax: 619-425-9057 | |
Maria E Castillejos, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 342 F St, Chula Vista, CA 91910 Phone: 619-422-1471 Fax: 619-422-0450 | |
Lina Amini, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1400 E Palomar St, Chula Vista, CA 91913 Phone: 619-397-3088 Fax: 619-397-3388 | |
Parnian Arjmand, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 835 Third Ave Ste A, Chula Vista, CA 91911 Phone: 619-425-7755 Fax: 619-425-2138 | |
Dr. Tayson Delengocky, D.O Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 835 3rd Ave, Suite A, Chula Vista, CA 91911 Phone: 619-425-7755 Fax: 619-425-2138 |